Ranibizumab Intraocular and Selegiline transdermal
Determining the interaction of Ranibizumab Intraocular and Selegiline transdermal and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: ranibizumab ophthalmic
Brand name: Lucentis
Synonyms: Ranibizumab (ophthalmic), Ranibizumab
Generic Name: selegiline
Brand name: Eldepryl, Zelapar, Emsam
Synonyms: Selegiline
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Ranibizumab Intraocular-Selegiline Transdermal System
- Ranibizumab Intraocular-Selenicaps-200
- Ranibizumab Intraocular-Selenimin
- Ranibizumab Intraocular-Selenimin-200
- Ranibizumab Intraocular-Selenious Acid
- Ranibizumab Intraocular-Selenious Acid Injection
- Selegiline transdermal-Ranibizumab ophthalmic
- Selegiline transdermal-Ranitidine
- Selegiline transdermal-Ranitidine Capsule
- Selegiline transdermal-Ranitidine Hydrochloride
- Selegiline transdermal-Ranitidine Injection
- Selegiline transdermal-Ranitidine Suspension